Top-News
  • Watchlist
  • Glocke

  • CAC 40 Index

    7.554,08 -0,05% -3,8624
    20.06.25 22:05:21 Ariva Indikation aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 969400
    ISIN: FR0003500008
    Typ: Index

    Weiter abwärts? Short handeln - Jetzt mit Hebel 5,82: MG4YW2
    Werbung

    Ad-hocs

    25.03.25 - GlobeNewswire
    Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
    Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
    24.03.25 - GlobeNewswire
    Annual General Meeting to be held on Tuesday 29 April 2025 and 2024 Universal Registration Document
    L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Tuesday 29 April 2025 and the 2024 ...
    24.03.25 - GlobeNewswire
    Press Release: Availability of the Q1 2025 Aide mémoire
    Availability of the Q1 2025 Aide mémoire Paris, France – March 24, 2025 . Sanofi announced today that its Q1 2025 Aide mémoire is available on the "Investors" page of the ...
    21.03.25 - GlobeNewswire
    Unibail-Rodamco-Westfield: Availability of the 2024 Universal Registration Document and terms for holding the Combined General Meeting of Unibail-Rodamco-Westfield SE on April 29, 2025
    Paris, March 21, 2025 Press release Availability of the 2024 Universal Registration Document and terms for holding the Combined General Meeting of Unibail-​Rodamco-Westfield ...
    20.03.25 - GlobeNewswire
    Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
    Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to ...
    10.03.25 - GlobeNewswire
    ArcelorMittal announces the publication of its 2024 annual report
    10 March 2025, 23.55 CET
    10.03.25 - GlobeNewswire
    ArcelorMittal publishes its Annual Report 2024 on Form 20-F
    ArcelorMittal has filed its Annual Report 2024 on Form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is now available at ...
    08.03.25 - GlobeNewswire
    Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
    Dupixent late-​breaking positive pivotal data in bullous pemphigoid presented at AAD
    05.03.25 - GlobeNewswire
    Press release: Sanofi successfully prices EUR 1.5 billion of bond issue
    Sanofi successfully prices EUR 1.5 billion of bond issue
    03.03.25 - GlobeNewswire
    ArcelorMittal appoints Everton Negresiolo as CEO of South American Long Products and mining business
    Jorge Luiz Ribeiro de Oliveira nominated Executive Vice President of ArcelorMittal
    25.02.25 - GlobeNewswire
    Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
    Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma  Approval offers access to new treatment options for newly diagnosed MM patients Approval based ...
    22.02.25 - GlobeNewswire
    Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
    ECCO 2025: new duvakitug data reinforce best-​in-class potential in ulcerative colitis and Crohn’s disease
    20.02.25 - EQS
    EQS-Adhoc: Airbus reports Full-Year (FY) 2024 results
    EQS-​Ad-hoc: Airbus SE / Key word(s): Annual Results Airbus reports Full-Year (FY) 2024 results 20-Feb-2025 / 06:30 CET/CEST Disclosure of an inside information acc. to Article 17 ...
    19.02.25 - GlobeNewswire
    Press Release: Sanofi and CD&R sign Opella share purchase agreement
    Sanofi and CD&R sign Opella share purchase agreement
    18.02.25 - GlobeNewswire
    Full-year 2024 results
    Media relations: Victoire Grux Tel.: +33 6 04 52 16 55 victoire.grux@capgemini.com Investor relations: Vincent Biraud Tel.: +33 1 47 54 50 87 vincent.biraud@capgemini.com Full-...
    18.02.25 - GlobeNewswire
    Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
    Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid If approved, Dupixent would be the first and only targeted medicine to treat BP in the ...
    17.02.25 - GlobeNewswire
    Change in the composition of Capgemini’s Board of Directors proposed to the 2025 Shareholders’ Meeting
    Media relations: Victoire Grux Tel.: +33 6 04 52 16 55 victoire.grux@capgemini.com Investor relations: Vincent Biraud Tel.: +33 1 47 54 50 87 vincent.biraud@capgemini.com ...
    13.02.25 - GlobeNewswire
    Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
    Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 13, 2025 . Sanofi announces today the ...
    13.02.25 - GlobeNewswire
    Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
    Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate didn’t ...
    07.02.25 - GlobeNewswire
    Press Release: Execution of a share buyback agreement for up to €2 billion
    Execution of a share buyback agreement for up to €2 billion Paris, February 7, 2025. On January 30, 2025 , Sanofi announced its intention to execute a share buyback program in ...

    Newssuche

    Videos

    newspaper
    20.06.25 +4,69%
    Technical Trading: Baumwolle Zukauf Chance
    Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »